CSL (Germany) Top Insiders

CSJA Stock  EUR 85.00  1.50  1.73%   
Examination of CSL's management performance can provide insight into the company performance.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CSL LTD SPONADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Symbol  CSJA
Name  CSL LTD SPONADR
TypeStock
Country  
 Germany
Exchange  F

Information on CSL LTD SPONADR Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

CSL Management Team Effectiveness

The company has return on total asset (ROA) of 0.0798 % which means that it generated a profit of $0.0798 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1964 %, meaning that it generated $0.1964 on every $100 dollars invested by stockholders. CSL's management efficiency ratios could be used to measure how well CSL manages its routine affairs as well as how well it operates its assets and liabilities.

CSL Workforce Comparison

CSL LTD SPONADR is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 131,905. CSL totals roughly 30,000 in number of employees claiming about 23% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.21 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.28 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.28.

CSL LTD SPONADR Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. CSL LTD SPONADR Price Series Summation is a cross summation of CSL price series and its benchmark/peer.

About CSL Management Performance

The success or failure of an entity such as CSL LTD SPONADR often depends on how effective the management is. CSL management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CSL management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CSL management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. CSL LTD operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange.

Complementary Tools for CSL Stock analysis

When running CSL's price analysis, check to measure CSL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSL is operating at the current time. Most of CSL's value examination focuses on studying past and present price action to predict the probability of CSL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSL's price. Additionally, you may evaluate how the addition of CSL to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Transaction History
View history of all your transactions and understand their impact on performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios